SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-001188
Filing Date
2021-08-10
Accepted
2021-08-10 16:26:42
Documents
56
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q janx-20210630.htm   iXBRL 10-Q 2309480
2 EX-31.1 janx-20210630ex31_1.htm EX-31.1 16577
3 EX-31.2 janx-20210630ex31_2.htm EX-31.2 15411
4 EX-32.1 janx-20210630ex32_1.htm EX-32.1 15465
  Complete submission text file 0000950170-21-001188.txt   6960322

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT janx-20210630.xsd EX-101.SCH 38881
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT janx-20210630_cal.xml EX-101.CAL 30403
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT janx-20210630_lab.xml EX-101.LAB 369611
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT janx-20210630_def.xml EX-101.DEF 157078
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT janx-20210630_pre.xml EX-101.PRE 268485
10 EXTRACTED XBRL INSTANCE DOCUMENT janx-20210630_htm.xml XML 1100423
Mailing Address 11099 TORREY PINES PARK ROAD SAN DIEGO CA 92037
Business Address 11099 TORREY PINES PARK ROAD SAN DIEGO CA 92037 858-750-4700
Janux Therapeutics, Inc. (Filer) CIK: 0001817713 (see all company filings)

IRS No.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40475 | Film No.: 211160278
SIC: 2834 Pharmaceutical Preparations